The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K83072125 TSA200767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 TSA200812-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 TSA200857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 TSA200902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 TSA200951-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 TSA200995-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 TSA201039-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 TSA201083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 TSF415758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF415759-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF415760-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF415761-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF415762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF415763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF416055-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF416056-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF416057-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF416058-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF416059-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF416060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF416351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF416352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF416353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF416354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF416355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF416356-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF416656-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF416653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF416657-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF416654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF416655-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF416658-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF416959-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF416957-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF416958-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF416960-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF416961-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF416962-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF417262-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF417259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF417260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF417261-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF417263-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF417264-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF417555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF417553-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF417554-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF417556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF417557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF417558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSF417847-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 10.0 µM for 24.0 h 1 subfactor(s) TSF417848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 3.33 µM for 24.0 h 1 subfactor(s) TSF417849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 1.11 µM for 24.0 h 1 subfactor(s) TSF417850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.37 µM for 24.0 h 1 subfactor(s) TSF417851-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.125 µM for 24.0 h 1 subfactor(s) TSF417852-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.04 µM for 24.0 h 1 subfactor(s) TSS415766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS415767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS415768-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS415769-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS415770-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS415771-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS416063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS416064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS416065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS416066-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS416067-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS416068-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS416359-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS416360-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS416361-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS416362-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS416363-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS416364-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS416664-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS416661-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS416665-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS416662-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS416663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS416666-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS416967-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS416965-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS416966-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS416968-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS416969-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS416970-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS417270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS417267-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS417268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS417269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS417271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS417272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS417563-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS417561-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS417562-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS417564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS417565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS417566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K83072125 0.04 µM for 24.0 h TSS417855-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 10.0 µM for 24.0 h TSS417856-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 3.33 µM for 24.0 h TSS417857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 1.11 µM for 24.0 h TSS417858-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.37 µM for 24.0 h TSS417859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.125 µM for 24.0 h TSS417860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K83072125 0.04 µM for 24.0 h
TSP48654 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K83072125
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided